Trinity Delta’s business is institutional quality issuer-paid equity research.

Our company coverage and past research notes can be accessed via the dedicated Company Pages below, or from our Research Library.

Allergy Therapeutics
Allergy Therapeutics is an international commercial biotechnology company focused on the treatment and diagnosis of allergies.
Read more
ANGLE is a world leading liquid biopsy company with sample to answer solutions based on its Parsortix CTC platform.
Read more
Arecor Therapeutics
Arecor is a revenue-generating clinical-stage drug developer. Its proprietary Arestat formulation platforms are the basis of an in-house and partnered pipeline of enhanced products with lower development risks and less onerous regulatory approvals.
Read more
Avacta is a biopharma company developing novel cancer immunotherapeutics, and high performing diagnostics, based on its two proprietary platforms: Affimer and pre|CISION.
Read more
Futura Medical
Futura Medical is an R&D driven small pharma with a novel DermaSys transdermal delivery system and a Phase III product (MED3000) for erectile dysfunction.
Read more
HUTCHMED, a Hong Kong-based biopharmaceutical company, developing and commercialising innovative, highly selective oral therapies for oncology indications.
Read more
MaxCyte has a patented flow electroporation platform for non-viral transfection of a wide array of cells. Key programmes at several partners are gaining greater visibility and approaching material value-inflection points.
Read more
Redx Pharma
Redx Pharma is a UK-based clinical stage drug discovery company that specialises in developing highly specific small molecules for cancer and fibrosis based on its proven medicinal chemistry platform.
Read more
Scancell is a clinical-stage immuno-oncology specialist that is developing two innovative and flexible therapeutic vaccine platforms, ImmunoBody and Moditope.
Read more

Subscribe to our research

Please sign up here to be added to our distribution database.